Ragene Rivera

1.4k citations

13 papers · 573 indexed · h-index 10

Impact in

Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
Cancer Research top 10%
- Breast Cancer Treatment Studies

Papers in ⓘ

Cancer Research 8
- Breast Cancer Treatment Studies 8
Oncology 9
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 1

Co-authors: Adam Brufsky (3 shared papers)Joyce O’Shaughnessy (4 shared papers)Joanne L. Blum (5 shared papers)Hope S. Rugo (2 shared papers)Vicente Valero (2 shared papers)Carol J. Fabian (2 shared papers)Jonathan Wright (1 shared paper)David A. Smith (1 shared paper)
Journals: Journal of Clinical Oncology (6 papers)Cancer Research (2 papers)Cancer (1 paper)Clinical Cancer Research (1 paper)The American Journal of Gastroenterology (1 paper)
Partner nations: United States Switzerland United Kingdom

In The Last Decade

Ragene Rivera

13 papers receiving 554 citations

Peers

Countries citing papers authored by Ragene Rivera

Since Specialization

Citations

This map shows the geographic impact of Ragene Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ragene Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ragene Rivera more than expected).

Fields of papers citing papers by Ragene Rivera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ragene Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ragene Rivera. The network helps show where Ragene Rivera may publish in the future.

Co-authors

The 25 scholars most cited alongside Ragene Rivera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ragene Rivera Line = papers co-authored together Ragene Rivera links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane Journal of Clinical Oncology ·Linda T. Vahdat, Brian Pruitt, Carol J. Fabian, Ragene Rivera, David A. Smith, Elizabeth Tan-Chiu, Jonathan Wright, Antoinette R. Tan, N. D'Acosta, Ellen Chuang, John W. Smith, Joyce O’Shaughnessy, Dale E. Shuster, Nicole Meneses, Kumari Chandrawansa, Fang Fang, Patricia E. Cole, Simon Ashworth, Joanne L. Blum	2009	201
2	Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial Breast Cancer Research and Treatment ·Adam Brufsky, Vicente Valero, B. Tiangco, Shaker R. Dakhil, Arija Brize, Hope S. Rugo, Ragene Rivera, Anja Duenne, N. Bousfoul, Denise A. Yardley	2012	103
3	Comparison of Menopausal Symptoms During the First Year of Adjuvant Therapy With Either Exemestane or Tamoxifen in Early Breast Cancer: Report of a Tamoxifen Exemestane Adjuvant Multicenter Trial Substudy Journal of Clinical Oncology ·Stephen E. Jones, James Cantrell, Svetislava J. Vukelja, John Pippen, Joyce O’Shaughnessy, Joanne L. Blum, Robert J. Brooks, Nicole L. Hartung, Angel G. Negron, Donald Richards, Ragene Rivera, Frankie A. Holmes, Sreeni Chittoor, T. Whittaker, James H. Bordelon, Steven J. Ketchel, Jennifer C. Davis, D. Ilegbodu, Jean Kochis, Lina Asmar	2007	63
4	RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab In Combination with Chemotherapy for Second-Line Treatment of HER2-Negative Metastatic Breast Cancer. Cancer Research ·Adam Brufsky, Igor Bondarenko, V. Yu. Smirnov, Sara A. Hurvitz, Edith A. Perez, Olga Ponomarova, Ihor Vynnychenko, Raji Swamy, Hua Mu, Ragene Rivera	2009	58
5	Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine Clinical Cancer Research ·Joyce O’Shaughnessy, Hartmut Koeppen, Yuanyuan Xiao, Mark R. Lackner, Devchand Paul, Christopher Stokoe, John Pippen, Lea Krekow, Frankie A. Holmes, Svetislava J. Vukelja, Deborah Lindquist, Scot Sedlacek, Ragene Rivera, Robert J. Brooks, Kristi McIntyre, Carrie Brownstein, Silke Hoersch, Joanne L. Blum, Stephen E. Jones	2015	37
6	Hepatoma presenting as a retro-orbital metastasis Cancer ·Mary Anne Zubler, Ragene Rivera, Montague Lane	1981	32
7	Abstract S4-2: First Efficacy Results of a Randomized, Open-Label, Phase III Study of Adjuvant Doxorubicin Plus Cyclophosphamide, Followed by Docetaxel with or without Capecitabine, in High-Risk Early Breast Cancer Cancer Research ·Joyce O’Shaughnessy, D Paul, Christopher Stokoe, John Pippen, JL Blum, Lea Krekow, FA Holmes, Svetislava J. Vukelja, Deborah Lindquist, Scot Sedlacek, Ragene Rivera, Robert J. Brooks, Kristi McIntyre, Robert Pluenneke, Jonathan Schwartz, Sharon Jones, Carrie Brownstein, Frank Gilberg	2010	29
8	Progression-free survival (PFS) in patient subgroups in RIBBON-2, a phase III trial of chemotherapy (chemo) plus or minus bevacizumab (BV) for second-line treatment of HER2-negative, locally recurrent or metastatic breast cancer (MBC). Journal of Clinical Oncology ·Adam Brufsky, Ragene Rivera, SA Hurvitz, Igor Bondarenko, Vitaliy Smirnov, Vicente Valero, Hope S. Rugo, Raji Swamy, Hua Mu, Edith A. Perez	2010	19
9	Post-Operative Adjuvant Radiochemotherapy in the Treatment of Gallbladder Cancer International Journal of Radiation OncologyBiologyPhysics ·Mercedes Rizo Baeza, Jose Reyes, Christie del Castillo-Hegyi, Ragene Rivera	2005	10
10	Randomized, phase III study of adjuvant doxorubicin plus cyclophosphamide (AC) → docetaxel (T) with or without capecitabine (X) in high-risk early breast cancer: Exploratory Ki-67 analyses. Journal of Clinical Oncology ·John Pippen, Devchand Paul, Christopher Stokoe, Joanne L. Blum, Lea Krekow, F. A. Holmes, Deborah Lindquist, Scot Sedlacek, Ragene Rivera, Robert J. Brooks, S. Vukelja, Kristi McIntyre, Christine Lopez‐Diaz, J. O’Shaughnessy	2011	9
11	Phase II study of eribulin mesylate (E7389) halichondrin b analog in patients with refractory breast cancer Journal of Clinical Oncology ·Joanne L. Blum, Brian Pruitt, Carol J. Fabian, Ragene Rivera, Dale E. Shuster, Nicole Meneses, Kumari Chandrawansa, Feng Fang, SZ Fields, Linda T. Vahdat	2007	7
12	Adjuvant capecitabine for invasive lobular/mixed early breast cancer (EBC): USON 01062 exploratory analyses. Journal of Clinical Oncology ·Joyce O’Shaughnessy, John Pippen, Devchand Paul, Christopher Stokoe, Joanne L. Blum, Lea Krekow, Frankie A. Holmes, Christine Lopez‐Diaz, Svetislava J. Vukelja, Deborah Lindquist, Scot Sedlacek, Ragene Rivera, Robert J. Brooks, Kristi McIntyre, Yunfei Wang	2012	3
13	S2120 Tirzepatide and MASLD: Real-World Outcomes in Patients With Overweight and Obesity The American Journal of Gastroenterology ·María Ángeles Espinosa, Sima Fansa, Diego Añazco, Wissam Ghusn, Tama Elif, Lizeth Cifuentes, Campos Alejandro, Ragene Rivera, Maria D. Hurtado, Andrés Acosta	2024	2

About Ragene Rivera

Ragene Rivera is a scholar working on Cancer Research, Oncology, Cell Biology, Pulmonary and Respiratory Medicine and Ophthalmology, having authored 13 papers that have together received 573 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (8 papers), HER2/EGFR in Cancer Research (3 papers), Advanced Breast Cancer Therapies (3 papers), Microtubule and mitosis dynamics (2 papers), Ocular Oncology and Treatments (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Oncology (473 citations), Cancer Research (197 citations), Pulmonary and Respiratory Medicine (142 citations), Dermatology (29 citations) and Cell Biology (43 citations). Ragene Rivera has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Adam Brufsky, Joyce O’Shaughnessy, Joanne L. Blum, Hope S. Rugo, Vicente Valero, Carol J. Fabian, Jonathan Wright, David A. Smith, Montague Lane and Simon Ashworth. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Cancer, Clinical Cancer Research and The American Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact